Related Experiment Video
Updated: Feb 10, 2026

Manufacturing Chimeric Antigen Receptor CAR T Cells for Adoptive Immunotherapy
Published on: December 17, 2019
Emerging role of immunotherapy for childhood cancers
Rupert Handgretinger1, Patrick Schlegel2
1Children's University Hospital, Department Hematology/Oncology, University of Tuebingen, Hoppe-Seyler-Strasse 1, Tuebingen, Germany. Rupert.Handgretinger@med.uni-tuebingen.de.
Abstract:
Recent developments in cell and gene therapy have a great impact on the new therapeutic approaches in pediatric cancers. Monoclonal antibodies for neuroblastoma and bispecific antibodies for leukemia have induced significant clinical responses for otherwise chemorefractory patients. Moreover, cellular therapeutic approaches including chimeric antigen receptor (CAR) T-cells as well as natural killer (NK) cells have the potential to cure patients with so far incurable malignancies and are the basis for future new therapies for pediatric cancer. Newer generations of cellular therapies, further development and improvement of such new strategies and their earlier use in therapeutic strategies will hopefully allow to significantly reduce the chemotherapeutic burden for children with cancer while increasing the cure rate.
Related Concept Videos
Tumor Immunotherapy
Emerging Adulthood
Introduction Cardiac Emergencies
Erikson's Theory on Socioemotional Development during Childhood
The first four of Erikson's eight...
Piaget's Theory of Cognitive Development from Childhood into Adulthood
Schemata: Building Blocks of Knowledge
Applications of GIS: Disaster Management and Emergency Response

